Diseases [C] - Female Urogenital Diseases and Pregnancy Complications [C13] Clinical Trials

195 clinical trials for Diseases [C] - Female Urogenital Diseases and Pregnancy Complications [C13] across international registries, including 9 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the effects of oral TRPC6 inhibitor BI 764198 taken over a 104 week treatment period in adult and adolescent participants with primary focal segmental glomerulosclerosis (pFSGS) or genetic FSGS related to TRPC6 gene variants — RECRUITING · PHASE3
• A phase 3b, Randomized, Controlled Trial of Nadofaragene Firadenovec vs. Observation in Subjects with Intermediate Risk Non-Muscle Invasive Bladder Cancer (IR NMIBC) — RECRUITING · PHASE3
• A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Povetacicept in Adults with Immunoglobulin A Nephropathy (RAINIER). — RECRUITING · PHASE3
• An Open-label, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Difelikefalin in Adolescents Aged 12 to 17 Years on Haemodialysis with Moderate-to-Severe Pruritus (KOR-PED-202) — RECRUITING · PHASE2
• MERCURE study: MEthotrexate in ReCurrent dVIN — RECRUITING · PHASE4
• A Phase 3, Multi-Center Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Risankizumab with Open-Label Induction, Randomized Double-Blind Maintenance, and Long-Term Extension Periods in Pediatric Subjects (2 to < 18 Years of Age) with Moderately to Severely Active Crohn's Disease — RECRUITING · PHASE3
• A randomized, double-blind, placebo-controlled study of daridorexant treatment in adolescents with enuresis: proof-of-concept. — RECRUITING · PHASE3
• Eight weeks of low dose hCG priming in women with diminished ovarian reserve undergoing IVF/ICSI – a randomized controlled trial — RECRUITING · PHASE3
• Impact of Analgesia on Success of External Version: Comparison of Spinal Anesthesia Versus Sedation; Prospective, Controlled, Randomized Study — RECRUITING · PHASE3
• Bioequivalence of Estradiol 10 mcg Vaginal Tablets in Healthy Women Participants. — NOT_YET_RECRUITING · PHASE1
• Statin Intervention for Severe Early-Onset Placental Insufficiency: A Randomized Controlled Trial Assessing daily Administration as a Treatment Strategy (STATIN-PRE trial) — TERMINATED · PHASE3
• A Phase III, randomized, multi-site, open-label trial of BNT323/DB-1303 versus investigator’s choice of chemotherapy in previously treated patients with HER2- expressing recurrent endometrial cancer — TERMINATED · PHASE3
• A study of different dose levels of FluBHPVE6E7 or placebo in women infected with the virus Human Papilloma Type 16 (HPV 16). — TERMINATED · PHASE1
• Pembrolizumab plus Lenvatinib in vulvar cancer patients: The prospective, multi-cohorts and multicentre, phase 2 MITO VULVA-01 study. — TERMINATED · PHASE2
• VALIDATION OF THE SENTINEL LYMPH NODE TECHNIQUE IN EARLY-STAGE OVARIAN CANCER (SENTOV II) — TERMINATED · PHASE3
• A multicenter, Phase Ib/II study to evaluate the safety, tolerability, pharmacokinetics and preliminary clinical activity of TUB-040, in combination with standard ovarian cancer drugs in patients with high-grade epithelial serous or endometrioid epithelial ovarian cancer (OC) (NAPISTAR 1-02) — TERMINATED · PHASE2
• A Phase 3, Randomized, Open-Label Study of Combination Therapy with Avutometinib plus Defactinib Versus Investigator’s Choice of Treatment in Patients with Recurrent Low-Grade Serous Ovarian Cancer (LGSOC) (RAMP301) — TERMINATED · PHASE3
• A Sequential Phase 2/3, Single-Arm, Open-Label Study in Adults Followed by a Randomized, Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults and Adolescents with Focal Segmental Glomerulosclerosis — NOT_YET_RECRUITING · PHASE3
• A Participant- and Investigator--Blinded, Placebo-Controlled, Randomized, Multipart, Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of OJR520 in Healthy Volunteers and Participants with Chronic Kidney Disease — NOT_YET_RECRUITING · PHASE1
• A RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERAPY WITH TSR-042 AND NIRAPARIB VERSUS STANDARD OF CARE PLATINUM-BASED THERAPY AS FIRST-LINE TREATMENT OF STAGE III OR IV NONMUCINOUS EPITHELIAL OVARIAN CANCER — TERMINATED · PHASE3
• Randomized, placebo-controlled, double-blind study to evaluate 2LPAPI® efficacy on the clearance of genital HR-HPV infections (PAPION study) — TERMINATED · PHASE4
• Paracervical block with ropivacaine for pain relief in second trimester medical abortion - a double blind placebo controlled randomized trial — NOT_YET_RECRUITING · PHASE3
• An open label, single-arm, phase 2 study of perioperative sacituzumab govitecan in combination with zimberelimab and domvanalimab for patients with muscle invasive bladder cancer ineligible for cisplatin-based chemotherapy. (PeRioperative Immunotherapy combined with Sacituzumab govitecan in Muscle invasive blAdder cancer) — TERMINATED · PHASE2
• Efficacy of oral bicarbonate versus placebo on the risk of assisted delivery in nulliparous women with prolonged labour (ProLabour): protocol fora randomized controlled trial — NOT_YET_RECRUITING · PHASE4
• Prospective trial of [18F]AlF-FAPI-74 for PET imaging of fibroblast activation protein in patients with endometriosis — NOT_YET_RECRUITING · PHASE2
• Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection via Hysteroscopy in pelvic pain suggestive of dysmenorrhea: A Prospective, Multicenter, Double-Blind, Randomized Placebo-Controlled Study. HYSTEROXINE Study — TERMINATED · PHASE3
• Calcium Electroporation for Urinary Bladder Tumors: A First-in-Human Feasibility, Safety, and Early Response Trial - The CALCIFER Trial — NOT_YET_RECRUITING · PHASE1
• Progesterone Luteal Support in Unexplained Infertility Management (PLUIM study) — NOT_YET_RECRUITING · PHASE4
• A phase 3, randomised, multi-center, open label trial to evaluate the safety and efficacy of intravesical nadofaragene firadenovec alone or in combination with chemotherapy (gemcitabine and docetaxel) or immunotherapy (pembrolizumab) in subjects with high-grade Bacillus Calmette-Guerin therapy (BCG) unresponsive non-muscle invasive bladder cancer (NMIBC) — TERMINATED · PHASE3
• A Randomized Phase III Study to Investigate the Efficacy and Safety of Alpha1H as a Neoadjuvant Therapy in Participants with Low- to Intermediate-Risk/Low-Grade Papillary Non-Muscle Invasive Bladder Cancer — NOT_YET_RECRUITING · PHASE3
• A study of niraparib in combination with abemaciclib for late line treatment of ovarian cancer: a single center, open label, single arm, phase Ib/II trial (NICHOL TRIAL) — TERMINATED · PHASE2
• The impact of ovarian stimulation with hMG on embryo quality in advanced age women. A randomized controlled trial — NOT_YET_RECRUITING · PHASE4
• Randomized, multicenter, open-label clinical trial to evaluate the clinical and microbiological impact of methenamine hippurate as an alternative prophylaxis to antibiotics in the management of recurrent urinary tract infections in women — NOT_YET_RECRUITING · PHASE4
• Luteal phase ovarian stimulation with Follitropin delta and dydrogesterone: a randomized cross over pilot trial — TERMINATED · PHASE4
• Usefulness of Corifollitropin alfa as alternative to conventional daily rFSH protocols in oocyte donors undergoing pituitary suppression with Medroxiprogesterona acetate (MPA). — TERMINATED · PHASE3
• A Phase 2 Study to Assess ADX-038 in Participants With Complement-Mediated Kidney Disease — TERMINATED · PHASE2
• A double-blind, randomized, placebo-controlled multicenter study to investigate efficacy and safety of elinzanetant for the treatment of vasomotor symptoms caused by adjuvant endocrine therapy, over 52 weeks and optionally for additional up to 3.5 years in women with, or at high risk for developing hormone-receptor positive breast cancer — TERMINATED · PHASE3
• A Phase 2, randomized, double-blind, placebo-controlled trial to investigate the efficacy and safety of 2 doses of vipoglanstat in patients with moderate to severe endometriosis-related pain – the NOVA trial — TERMINATED · PHASE2
• To evaluate the pharmacokinetics and safety of nolasiban — TERMINATED · PHASE1
• Optimising the protocol of labour induction using misoprostol – randomised open-label clinical trial (OPTIMISO) — TERMINATED · PHASE4
• Intranasal nafarelin compared to subcutaneous triptorelin for triggering final oocyte maturation in ovarian stimulation: a non-inferiority randomised controlled clinical trial — NOT_YET_RECRUITING · PHASE4
• Protocol with Progestin-primed Ovarian Stimulation (PPOS) in conventional treatment from the start of stimulation vs protocol with GnRH antagonists as a pituitary suppressor in patients who are going to undergo DUOSTIM with embryo accumulation for PGT-A of the embryos. — TERMINATED · PHASE4
• Exogenous progesterone as ovulation trigger – a pilot study — NOT_YET_RECRUITING · PHASE4
• A Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multicenter Trial Evaluating the Effects of Two Dosing Regimens of Nolasiban on Uterine Contractility and Endocrine Parameters — TERMINATED · PHASE2
• Measuring Oncological Value of Exercise and Statin (MOVES) — TERMINATED · PHASE3
• Treatment Of Metastatic Bladder cancer at the time Of biochemical reLApse following radical cystectomy - TOMBOLA — TERMINATED · PHASE4
• A PHASE 3, RANDOMIZED, DOUBLE-BLIND, MULTICENTER STUDY OF DOSTARLIMAB (TSR-042) PLUS CARBOPLATIN-PACLITAXEL VERSUS PLACEBO PLUS CARBOPLATIN-PACLITAXEL IN PATIENTS WITH RECURRENT OR PRIMARY ADVANCED ENDOMETRIAL CANCER (RUBY) — TERMINATED · PHASE3
• Effect of low-dose arginine-vasopressin supplementation on post-transplant Acute Kidney Injury after liver transplantation - AVENIR Trial — TERMINATED · PHASE3
• A Phase 1/2, Single-arm, Open-Label Trial to Evaluate the Safety and Efficacy of Nadofaragene Firadenovec Instilled to the Renal Pelvis in Adult Subjects with Low-Grade Upper Tract Urothelial Carcinoma (LG-UTUC) — NOT_YET_RECRUITING · PHASE2
• Metformin for the prolongation of pregnancy in preterm preeclampsia: the PI-NL trial — TERMINATED · PHASE3

Refine this search